PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease
Trial details
- Registry ID
- NCT01155362
- Phase
- Phase 2
Drug identity checked against registry records
| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's DiseaseNCT01155362 | Celularity Incorporated | Phase 2 | Completed | 2012-02Actual |
| No regulatory events match this view.This does not mean no FDA events have occurred. |